When the clinical suspicion of MG arises, anti-AChR antibodies are first tested, followed by Anti-MuSK in AChR-negatives, according to the Italian recommendations for the diagnosis and treatment of myasthenia gravis [5]. The gene discussed is MUSK; the disease is myasthenia gravis.